Redcare Pharmacy NVXSWX:RDC 48 3-Year ROIIC % is 14.65 as of Dec. 2025. GuruFocus rates XSWX:RDC with a GF Score™ of 48/100 and a GF Value™ of CHF143.20 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 621 Healthcare Providers & Services companies, Redcare Pharmacy NV ranks better than 69.57% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Redcare Pharmacy NV's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 14.65%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Redcare Pharmacy NV's 3-Year ROIIC % or its related term are showing as below:
XSWX:RDC's 3-Year ROIIC % is ranked better than 69.57% of 621
companies
in the Healthcare Providers & Services industry
Industry Median: 2.62
vs XSWX:RDC: 14.65
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Redcare Pharmacy NV 3-Year ROIIC % Related Terms
Redcare Pharmacy NV 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Redcare Pharmacy NV's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Redcare Pharmacy NV's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Redcare Pharmacy NV 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Redcare Pharmacy NV's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Redcare Pharmacy NV's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Redcare Pharmacy NV (XSWX:RDC) has a 3-Year ROIIC % of 14.65 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Redcare Pharmacy NV and its competitors. According to the industry distribution chart, Redcare Pharmacy NV ranks #189 out of 621 companies in the Healthcare Providers & Services industry, placing it in the top 30.4%.
Is Redcare Pharmacy NV's 3-Year ROIIC % too high?
Redcare Pharmacy NV's current 3-Year ROIIC % is 14.65. The Healthcare Providers & Services industry median 3-Year ROIIC % is 2.62. Redcare Pharmacy NV's value of 14.65 is 459.2% above this industry median. Based on the distribution chart, Redcare Pharmacy NV ranks #189 out of 621 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Redcare Pharmacy NV has a GF Score™ of 48/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Redcare Pharmacy NV's 3-Year ROIIC % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Redcare Pharmacy NV ranks #189 out of 621 companies for 3-Year ROIIC %. This puts Redcare Pharmacy NV in the upper half of its industry. The industry median 3-Year ROIIC % is 2.62. Redcare Pharmacy NV's value of 14.65 is 459.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 2.62, based on 621 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Redcare Pharmacy NV's current 3-Year ROIIC % of 14.65 is 459.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Redcare Pharmacy NV and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 2.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Redcare Pharmacy NV's current 3-Year ROIIC % is 14.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redcare Pharmacy NV stock overvalued right now?
Based on GuruFocus' analysis, Redcare Pharmacy NV (XSWX:RDC) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF143.20, compared to a current price of CHF60.95 — trading 57.4% below its estimated fair value. The current 3-Year ROIIC % is 14.65 and 459.2% above the Healthcare Providers & Services industry median of 2.62. Redcare Pharmacy NV's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Redcare Pharmacy NV (XSWX:RDC), the current 3-Year ROIIC % is 14.65 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Redcare Pharmacy NV (XSWX:RDC) Overvalued in 2026?
Based on GuruFocus' analysis, Redcare Pharmacy NV stock appears to be undervalued.
The current stock price of CHF60.95 is trading 57.4% below its estimated GF Value™ of CHF143.20.
GuruFocus considers Redcare Pharmacy NV to be Significantly Undervalued.
Key valuation signals for XSWX:RDC:
3-Year ROIIC %: 14.65
GF Value™: CHF143.20 vs. price of CHF60.95 (57.4% below fair value)
Industry Position: 459.2% above the Healthcare Providers & Services median (#189 of 621)
No single metric tells the full story. See the XSWX:RDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Redcare Pharmacy NV is an online pharmacy business for prescription and nonprescription (over-the-counter) pharmaceuticals, beauty and personal care products (BPC) and food supplements. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands. It operates in two segments, namely DACH segment that includes sales in Germany, Austria and Switzerland; and the International segment that includes sales across Belgium, the Netherlands, France and Italy. The DACH segment accounts for the majority of the revenue.
48GF Score
Get the complete analysis for XSWX:RDC
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:RDC has been successfully added to your 
